Phosphorus pentachloride → HCID 89813529, compound

HRID 2172301Notes

Reaction equation

HRID 2172301 reaction equation
[S:1]1[C:5]([NH:6][S:7](=[O:10])(=[O:9])[O-])=[N:4][CH:3]=[N:2]1.[Na+].P(Cl)(Cl)(Cl)(Cl)Cl.S(=O)(=O)(OC)N.Cl.[Br:25][C:26]1[CH:35]=[CH:34][CH:33]=[C:32]2[C:27]=1[CH2:28][CH2:29][NH:30][CH2:31]2>C(Cl)Cl.C(=O)(O)[O-].[Na+]>[Br:25][C:26]1[CH:35]=[CH:34][CH:33]=[C:32]2[C:27]=1[CH2:28][CH2:29][N:30]([S:7]([NH:6][C:5]1[S:1][N:2]=[CH:3][N:4]=1)(=[O:9])=[O:10])[CH2:31]2

Participants

7

Conditions

Temperature
50 °C

Procedure

To a 50 mL flask containing sodium 1,2,4-thiadiazol-5-ylsulfamate (Intermediate A, 96 mg, 0.472 mmol) and 10 mL of DCM was added PCl5 (Aldrich, St. Louis, Mo., 245 mg, 1.179 mmol). The resulting slurry was heated at 50° C. for 1.5 hours. LCMS showed conversion to the methyl sulfamate (following quench into methanol). The reaction was cooled to rt and was quenched with the addition of 5 drops of brine. The resulting slurry was stirred vigorously for 5 minutes before being filtered through a plug of diatomaceous earth, washing well with DCM. The mixture was concentrated under reduced pressure. The derived oil was taken up in 1 mL of DCM and was added to a solution of 5-bromo-1,2,3,4-tetrahydroisoquinoline hydrochloride (ASW Medchem, 50 mg, 0.236 mmol) and TEA (164 μl, 1.179 mmol) in 2 mL of DCM at 0° C. Another 0.164 mL of TEA was added and the reaction allowed to warm to room temperature where it was maintained for 2 hours. LCMS showed clean conversion to sulfonamide. The reaction was allowed to stir overnight before being diluted with saturated sodium bicarbonate (10 mL) and poured into a separatory funnel containing methylenechloride (10 mL). The layers were separated and the aqueous layer was extracted with methylenechloride (2×25 mL). The combined organic layers were washed with brine, dried over sodium sulfate, filtered and concentrated under a vacuum to provide a yellow oil that was purified by silica gel chromatography (Redi-Sep pre-packed silica gel column (12 g), 0-10% methanol in methylenechloride) to provide 5-bromo-N-(1,2,4-thiadiazol-5-yl)-3,4-dihydroisoquinoline-2(1H)-sulfonamide as an off white solid. [M+H]+=375.0 1H NMR (400 MHz, Acetone) δ ppm 8.28 (s, 1H), 7.96 (s, 1H), 7.45-7.50 (m, 1H), 7.09-7.20 (m, 2H), 4.32 (s, 2H), 3.48 (t, J=6.1 Hz, 2H), 2.86-2.92 (m, 2H)

Workup

  1. temperatureThe reaction was cooled to rt
  2. customwas quenched with the addition of 5 drops of brine
  3. filtrationbefore being filtered through a plug of diatomaceous earth
  4. washwashing well with DCM
  5. concentrationThe mixture was concentrated under reduced pressure
  6. temperatureto warm to room temperature where it
  7. temperaturewas maintained for 2 hours
  8. stirringto stir overnight
  9. additionpoured into a separatory funnel
  10. customThe layers were separated
  11. extractionthe aqueous layer was extracted with methylenechloride (2×25 mL)
  12. washThe combined organic layers were washed with brine
  13. dry with materialdried over sodium sulfate
  14. filtrationfiltered
  15. concentrationconcentrated under a vacuum
  16. customto provide a yellow oil that
  17. customwas purified by silica gel chromatography (Redi-Sep pre-packed silica gel column (12 g), 0-10% methanol in methylenechloride)

Sources & evidence

ORD record
ord-9a3278588c144f359d06c3c56b6af4db
Source dataset
uspto-grants-2015_06
Patent number
US09051311B2

Reaction notes

Loading…